Treatment Trends for Neovascular AMD 2003-2006

It’s interesting to review the treatment trends for neovascular AMD over the last four years. Below are tables of the various treatments performed in our main vitreoretinal clinic at the University of Iowa. PDT was king in 2003 and 2004. Macugen and PDT were used about equally in 2005. Avastin took over in late 2005. Avastin and Lucentis dominated in 2006. The number of Lucentis injections is increasing but Avastin is holding fairly steady. The PDTs done later in 2006 were often used in combination with Avastin or Lucentis.

Total 2003
PDT	327

Total 2004
PDT	390

Total 2005
PDT	330
Avastin	104
Macugen	296

2006	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Total 2006
Avastin	56	59	74	93	95	103	68	92	88	76	82	73	959
Kenalog	-	-	-	-	-	-	1	13	10	6	3	3	36
Lucentis	-	-	-	-	-	-	39	96	98	111	94	113	551
Macugen	26	14	14	12	11	2	3	5	4	3	2	2	98
PDT	18	14	7	-	4	7	3	2	1	3	6	9	74